EGFR and neoplasm: These data suggest that E-cadherin is able to negatively regulate mitogenic signalling in tumours mediated by EGFR and that E-cadherin may have an inhibitory effect on numerous RTKs, a phenotype observed in many tumours [73, 75, 76].